Reactogenicity, Safety and Immunogenicity of a LAIV А/17/Hong Kong/2017/75108 H7N9 Influenza Vaccine

NCT03739229 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Vaccine Adverse Reaction

Interventions

BIOLOGICAL: Placebo
BIOLOGICAL: H7N9 LAIV

Sponsor

Research Institute of Influenza, Russia

Collaborators

[object Object]
[object Object]
[object Object]